Published in AIDS Weekly, February 10th, 2003
J. Miller and colleagues at St. Vincent's Hospital conducted a study "to explore the efficacy and safety of gemfibrozil for hypertriglyceridemia in patients with HIV infection."
"Following a 4-week period of dietary intervention alone, patients were randomized to gemfibrozil or matching placebo," the researchers wrote. "37 men were randomized (17 gemfibrozil, 20 placebo) with median fasting triglycerides 5.6...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.